Michael Shih

Michael Shih joined Kite in 2022 and currently serves as Vice President of Corporate Development.

Prior to joining Kite, Michael was the Head of Business Development at Biogen, responsible for overseeing the evaluation and execution of all business development opportunities, including collaborations, licenses, joint ventures and mergers and/or acquisitions. Before Biogen, Michael was VP, Head of Global Transactions at Sanofi, where he oversaw the structuring and negotiation of business development transactions across Sanofi’s business units. Michael has also held senior business development roles at Epizyme, Forest Laboratories and Eisai. An attorney by training, Mr. Shih previously practiced law at several New York firms and held senior legal positions in-house at Eisai Inc., specializing in licensing, corporate transactions, and litigation.

Michael holds a bachelor’s degree in molecular and cellular biology from Cornell University, a master’s degree in biology from the University of Illinois and a law degree from Fordham University School of Law.